
Rudi's View | Jan 15 2026
This story features NORTHERN STAR RESOURCES LIMITED, and other companies.
For more info SHARE ANALYSIS: NST
The company is included in ASX20, ASX50, ASX100, ASX200, ASX300 and ALL-ORDS
Updates on Conviction Calls, Best Buys and most favoured sector picks ahead of the February results season.
By Rudi Filapek-Vandyck, Editor
In less than two weeks –can you believe it?– the February results season will be upon us.
Initial signals are patchy, though not necessarily representative.
Gold producer Northern Star ((NST)) started the year with a disappointing market update and the same observation can be made for Super Retail ((SUL)), Endeavour Group ((EDV)) and –earlier today–Amaero ((3DA)).
I am less familiar with smaller cap stories behind Biome Australia ((BIO)), Carma ((CMA)), TMK Energy ((TMK)), and Metro Mining ((MMI)), but in all cases the share price reaction has been negative. Biome’s share price has since recovered (almost).
Have thus far seen their share price respond positively post market update: Codan ((CDA)), Nexsen ((NXN)), Ryman Healthcare ((RYM)), and Kingsgate Consolidated ((KCN)).
Decidre AI Industries Ltd ((DAI)) –market cap $174m– issued an update on January 8 which initially saw its share price rally in response, but none of that proved sustainable and –no surprise to those owning technology and/or AI-related equities– selling orders came thick and fast next.
Decidre shares are now noticeable weaker than previously. In Australia, growth and technology remain out-of-favour, no matter the market update (or so it still appears).
According to the ASX website: “Decidr AI Industries enables businesses to use Generative and Agentic Artificial Intelligence, unlocking new levels of productivity, automation, and personalized customer engagement.”
I might be reading too much into these early signs, but my inclination is to expect a continuation of the trend that started during results season in February last year: above average volatility with higher spikes and falls, and in much higher numbers.
It might be an apposite strategy to hold cash in advance. There might be opportunities galore with eyes firmly on the longer-term horizon.
Corporate USA – Trends
Apart from a handful of early reporters, such as Alcoa ((AAI)), Credit Corp ((CCP)) and ResMed ((RMD)), it’ll still be a good month before corporate Australia unleashes its financial performances into the public arena.
Before then, there’s plenty to pay attention to, and to possibly take guidance from, during the quarterly reporting season in the USA. Early signals over there are equally rather patchy.
An at face value better-than-expected quarterly performance by JP Morgan resulted in a weaker share price and the likes of Bank of America, Citi and Wells Fargo have equally found the bar for further share price upside has been lifted.
Once again, with indices at or near all-time record highs, and after three years of double digit percentage returns, corporate results are being touted as at an important inflection point. After all, those “expensive” looking share prices need to be confirmed and verified.
Or so the narrative goes.
I am sure investors get a bit tired of hearing the same warnings over and over again. Which is not to say a bad reporting season couldn’t possibly put a dent in the hereto irresistible market enthusiasm and optimism.
In the lead-in, risk appetite remains high and analysts have been lifting their forecasts in direct contravention to the usual seasonal pattern. As analysts at Blackrock put it: solid economic growth combined with Fed rate cuts have boosted earnings and profit margins.
Now add the prospect of AI-driven efficiencies and (expectations of) active stimulus from the Trump administration and there should be no secrets as to where all this optimism stems from. But that’s only half of the story, at best.
One of the ruling narratives is that cyclicals and small caps will outperform Megacaps and yesteryear’s AI Champions and that thesis will surely be put under the microscope over the coming weeks.
In Australia the one sector that has noticeably enjoyed an uptick in earnings forecasts –well above the rest of the market– is Materials.
For good measure: the Magnificent7 are still projected to grow strongly. It’s the gap with the remaining 493 that make up the S&P500 that is expected to narrow significantly.
Watch this space. This might be one reporting season that lives up to the hype of being “very, very important”.
Plenty of US strategists and investment advisors continue to support the Megacaps and AI Champions, though none of that is mirrorred in Australia. Here one of the big questions remains: when will the bear market for Quality, Technology and Growth stocks end?
Not sure whether February might/can produce enough answers to that question. Maybe fear for imminent RBA tightening needs to dial down? Maybe the Nasdaq needs to have a sizeable wobble first?
So far, and no matter the narrative or personal perspective, one observation stands as a rock in Australia: selling orders still dominate share prices for Pro Medicus ((PME)), TechnologyOne ((TNE)), WiseTech Global ((WTC)), Xero ((XRO)), and the likes.
That’s extraordinary given most share prices started weakening in July last year. Bear markets are, indeed, truly brutal.
Just ask any investor who held shares in Pilbara Minerals ((PLS)) in 2024 or Woodside Energy ((WDS)) shares since 2023.
Early Previews
Analysts are by no means back in full action mode this early in the new year (judging from the many email bounces: neither are investors and advisors) but the first previews are cautiously being issued.
Banking analysts at Jarden are wondering whether 2026 could actually become the year when a repricing of bank deposits could turn into a headwind for most inside the sector?
CommBank ((CBA)) could potentially re-ignite market concerns about pressure on the net interest margin (NIM), while Bendigo and Adelaide Bank ((BEN)) is yet to reveal provisions (market is apparently waiting for it) and Judo Bank ((JDO)) might yet again showcase its disruptive business is truly operating in a sweetspot.
Jarden also suggests the upcoming Q3 trading update from Macquarie Group ((MQG)) could turn into a positive event on the back of a general pick-up in capital markets and upward volatility in commodities.
Then what else is the share market but a melting pot of conflicting narratives and approaches?
Banking sector analysts at Citi are expecting positive follow-through from deposit pricing with banks expected to issue cautiously positive outlook statements. They too are positively-biased towards Macquarie Group’s update, also because last year’s comparables were quite soft.
To express their positive view on Judo Bank, Citi analysts have opened a positive 90 days catalyst watch on the stock.
As per usual, not everything will be straightforward negative or positive in February. Jarden’s preview on The Lottery Corp ((TLC)), for example, implies the interim result is likely to be weak (with Jackpot weakness to blame) –with downside risk seen to consensus forecasts– but with the added thought this might well already be in today’s share price.
No double-guessing as to what are Jarden’s thoughts about the current set-up: earlier this morning, this broker upgraded its rating to Overweight from Underweight. Target $5.30 (up by 10c) on positive revisions to longer-term growth projections.
To be continued over the following weeks.
Conviction Calls and Best Buys
Jarden’s Favourites
The following sentence stands out in Jarden’s latest sector update for ASX-listed REITs:
“We are increasingly bullish on residential names given recent underperformance, structural undersupply, government policy support, pipeline restocking measures and strong volume momentum.”
Most preferred names:
Least preferred:
Elsewhere at the retail sector desk, the broker’s favourites are:
plus Sigma Healthcare ((SIG)) for defensive growth and Flight Centre ((FLT))
Least preferred ( “most challenged”):
Citi’s Growing Real Estate Optimism
The Australian Real Estate Team at Citi believes strong sector fundamentals will trump investor concerns about (potentially) higher interest rates in 2026.
As such, Citi is increasingly optimistic about the outlook for A-REITs.
Sector Top Picks:
- Goodman Group ((GMG))
- Stockland ((SGP))
- Charter Hall ((CHC))
- Ingenia Communities Group ((INA))
- Scentre Group ((SCG))
- GPT Group ((GPT))
Among small/mid stocks the preference goes to:
Ord Minnett’s Convictions
Ord Minnett’s selection of Analysts’ Conviction Stocks has seen the addition of Shape Australia Corp ((SHA)) in December.
The rest of the list remains:
- Aussie Broadband ((ABB))
- Beacon Lighting Group ((BLX))
- Brazilian Rare Earths ((BRE))
- Cuscal ((CCL))
- Energy One ((EOL))
- Lindsay Australia ((LAU))
- Qoria ((QOR))
- Ramelius Resources ((RMS))
- Regis Healthcare ((REG))
- SiteMinder ((SDR))
- Zip Co ((ZIP))
RaaS’ Micro Cap Favourites
The team of inhouse analysts at Research as a Service (RaaS) has selected the following candidates believed to be primed for outperformance in 2026:
- Acusensus ((ACE))
- Adairs ((ADH))
- Australian Vintage ((AVG))
- Artrya ((AYA))
- Beforepay ((B4P))
- Raiz Invest ((RZI))
- Saturn Metals ((STN))
- Unico Silver ((USL))
UBS’ Tech Opportunities
The underperformance of ASX-listed large-cap software companies has gone way too far, according to analysts at UBS.
They now see “significant re-rate opportunity”.
The sentence that summarises it nicely: “we remain positive around Software’s defensive moat against AI, continued strength in pricing power and the sector’s ability to monetise agentic AI investments, all of which could drive a meaningful re-rate through the course of the year”.
UBS has reiterated its Buy ratings for:
- TechnologyOne ((TNE)) – price target $38.70
- WiseTech Global ((WTC)) – price target $115
- Xero ((XRO)) – price target $194
FNArena’s Corporate Results Monitor will soon close off on the season post August and dedicate all its attention to the February season ahead: https://fnarena.com/index.php/reporting_season/
The All-Weathers section: https://fnarena.com/index.php/analysis-data/all-weather-stocks/
Make sure you also read: https://fnarena.com/index.php/2025/12/24/rudis-view-best-buys-favourites-for-2026/
(Do note that, in line with all my analyses, appearances and presentations, all of the above names and calculations are provided for educational purposes only. Investors should always consult with their licensed investment advisor first, before making any decisions.)
P.S. I – All paying members at FNArena are being reminded they can set an email alert for my Rudi’s View stories. Go to My Alerts (top bar of the website) and tick the box in front of ‘Rudi’s View’. You will receive an email alert every time a new Rudi’s View story has been published on the website.
P.S. II – If you are reading this story through a third party distribution channel and you cannot see charts included, we apologise, but technical limitations are to blame.
FNArena Subscription
A subscription to FNArena (6 or 12 months) comes with an archive of Special Reports (20 since 2006); examples below.



